ZTS | ZOETISNYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history

$82.99
-$0.19 (-0.23%)

ZOETIS (ZTS) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2019.

The 50 SMA sits below the 200 on the daily, with no cross projected inside the 30 bars Cruxta tracks. Price sits between the 50 and the 200 on the daily, below both on the weekly and above both on the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
between the two $82.99 vs 50 $75.27 / 200 $93.11
Projection
No cross projected
Test
No active test
Last cross
Death cross 30 Dec 2024 ยท projected 27 bars out

Weekly as of 30 Oct 16:00 ET

Price
below both $79.72 vs 50 $98.37 / 200 $152.10
Projection
No cross projected
Test
No active test
Last cross
Death cross week of 16 Dec 2024 ยท projected 11 bars out ยท tested 1 bar

4-hour as of 3 Nov 16:00 ET

Price
above both $82.99 vs 50 $76.68 / 200 $75.57
Projection
No cross projected
Test
Cross test window open, no test bar yet
Last cross
Golden cross 30 Oct 2026 ยท projected 30 bars out

Cross history

26
crosses on record since 2019
12 golden14 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
30 Oct 2026Golden4-hour30 bars outActive Cross Test
15 Jul 2025Death4-hour29 bars outโ€”
6 Jun 2025Golden4-hour30 bars outโ€”
30 Dec 2024Deathdaily27 bars outNot tested
week of 16 Dec 2024Death flatweekly11 bars out1 bar cross test

About ZTS

ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$310M
4-hour coverageYes, since Oct 2025
History on recordSince 2019
SectorHealthcare
Cap bandlarge

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.